CCL20 and neoplasm: Immunohistochemistry results showed that CCL20 expression in tumor tissues was obviously higher than that in peritumor tissues (P < 0.001, Fig. 1e), and similarly higher levels were observed in tumor tissues from Folfox-resistant patients who received neoadjuvant chemotherapy (Fig. 1e).